Hallek, M <br/><br/>
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study Group.  [electronic resource] 

 -  British journal of haematology  Aug 2001 
 - 342-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2141.2001.02959.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Leukopenia--chemically induced<br/>Male<br/>Middle Aged<br/>Neutropenia--chemically induced<br/>Thrombocytopenia--chemically induced<br/>Treatment Outcome<br/>Vidarabine--administration & dosage